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Abstract
Background: Conventional type 1 dendritic cells (cDC1s) control anti-viral and 
anti-tumor immunity by inducing antigen-specific cytotoxic CD8+ T-cell responses. 
Controversy exists whether cDC1s also control CD4+ T helper 2 (Th2) cell responses, 
since suppressive and activating roles have been reported. DC activation status, con-
trolled by the transcription factor NF-κB, might determine the precise outcome of 
Th-cell differentiation upon encounter with cDC1s. To investigate the role of acti-
vated cDC1s in Th2-driven immune responses, pulmonary cDC1s were activated by 
targeted deletion of A20/Tnfaip3, a negative regulator of NF-κB signaling.
Methods: To target pulmonary cDC1s, Cd207 (Langerin)-mediated excision of 
A20/Tnfaip3 was used, generating Tnfaip3fl/flxCd207+/cre (Tnfaip3Lg-KO) mice. Mice 
were exposed to house dust mite (HDM) to provoke Th2-mediated immune responses.
Results: Mice harboring Tnfaip3-deficient cDC1s did not develop Th2-driven eo-
sinophilic airway inflammation upon HDM exposure, but rather showed elevated 
numbers of IFNγ-expressing CD8+ T cells. In addition, Tnfaip3Lg-KO mice harbored 
increased numbers of IL-12–expressing cDC1s and elevated PD-L1 expression in all 
pulmonary DC subsets. Blocking either IL-12 or IFNγ in Tnfaip3Lg-KO mice restored 
Th2 responses, whereas administration of recombinant IFNγ during HDM sensitiza-
tion in C57Bl/6 mice blocked Th2 development.
Conclusions: These findings indicate that the activation status of cDC1s, shown by 
their specific expression of co-inhibitory molecules and cytokines, critically contrib-
utes to the development of Th2 cell–mediated disorders, most likely by influencing 
IFNγ production in CD8+ T cells.
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1  | INTRODUC TION
T helper (Th) 2-mediated diseases such as allergic asthma affect peo-
ple all over the world. Th2 cytokines facilitate the classical allergic 
response, such as IgE class switching by B cells (IL-4), eosinophilic in-
flammation (IL-5), and goblet cell hyperplasia (IL-13).1 Dendritic cells 
(DCs) are potent antigen-presenting cells that induce the differen-
tiation of naïve Th cells into Th2 cells or various other T helper cell 
subsets. Based on surface markers and transcription factor expression, 
two main conventional DC (cDC) subsets can be identified: type 1 
cDCs (cDC1s) and cDC2s.2 During inflammation, a third population of 
monocyte-derived DCs (moDCs) arises.3 IRF-4–dependent cDC2s are 
considered to be efficient at priming CD4+ T cells through MHC class 
II-restricted antigen (Ag) presentation.4-6 Upon allergen inhalation, 
cDC2s drive Th2 differentiation, whereas moDCs maintain Th2 inflam-
mation through local secretion of chemokines.7 cDC1s have superior 
Ag-cross-presenting capabilities and play pivotal roles in antiviral and 
antitumor immunity through the induction of antigen-specific cyto-
toxic CD8+ T-cell responses.8,9 Conflicting data exist concerning cDC1 
function in Th2-mediated diseases, whereby cDC1s were reported to 
either suppress allergic airway inflammation,10-12 be redundant,7,11 or 
essential for Th2 immune responses.13-15 During experimental hel-
minth infection, cDC1s limit the amplitude of Th2 immune responses 
through their IL-12 production.16
DC activation is needed for proper Th-cell differentiation into Th1, 
Th2, and Th17cells.17 Although there is evidence that pattern recogni-
tion receptors (PRRs) on lung epithelial cells contribute to allergic air-
way inflammation,18 activation of DCs in Th2-mediated diseases also 
often occurs through allergen-mediated triggering of PRRs on DCs.19 
PRR triggering on DCs activates the transcription factor NF-κB, which 
initiates transcription of pro-inflammatory cytokines. NF-κB activa-
tion is negatively regulated by TNFAIP3 (TNFα-induced protein 3, also 
known as A20), a ubiquitin-modifying enzyme that can (de)ubiquitinate 
several NF-κB signaling molecules to terminate NF-κB activation.20,21 
Several models of DC-specific deletion of TNFAIP3 in CD11chi cells 
have shown that this molecule limits DC activation, and in the absence 
of TNFAIP3, DCs produce higher levels of cytokines, express higher 
co-stimulatory molecules, resist to cell death, and activate auto-re-
active T- and B-cell responses.22,23 TNFAIP3 is also implicated in al-
lergic disorders in humans, as genetic polymorphisms in the TNFAIP3 
and TNFAIP3 interacting protein (TNIP) loci have been associated with 
asthma and allergies.24-26 Also, reduced TNFAIP3 expression in pe-
ripheral blood mononuclear cells was observed in asthmatic children 
compared healthy controls.27 Recently, we found that increasing the 
activation status of DCs by ablation of the Tnfaip3 gene in myeloid 
cells induced a neutrophilic inflammation in a house dust mite (HDM)-
mediated murine asthma model, which was accompanied by elevated 
numbers of Th17-cells.23
K E Y W O R D S
A20/Tnfaip3, CD8+ T cells, interferon gamma, Th2-driven airway inflammation, Type 1 
conventional dendritic cells
G R A P H I C A L  A B S T R A C T
Mice harboring Tnfaip3-deficient cDC1s (Tnfaip3Lg-KO mice) do not develop Th2-driven eosinophilic airway inflammation upon house dust 
mite exposure but have elevated numbers of pulmonary IFNγ-expressing CD8+ T-cells. In the lungs of Tnfaip3Lg-KO mice, cDC1s have 
increased IL-12 and PD-L1 expression. Both IL-12 and IFNγ are involved in the reduced Th2-response observed in Tnfaip3Lg-KO mice.
Abbreviations: cDC, conventional dendritic cell; PD-L1, programmed death ligand 1; Tnfaip3, TNFα-induced protein 3.
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However, whether TNFAIP3 levels in cDC1s affect the develop-
ment of asthma is currently unknown. Therefore, in this study, we in-
vestigated whether TNFAIP3 depletion in cDC1s would affect their 
activation status and thereby affect asthma development. To this 
end, we crossed Tnfaip3 floxed mice22 with a transgenic mouse line 
that expresses Cre under the control of the Langerin (Cd207) pro-
motor, which targets Langerin-expressing cDC1s,28 and performed 
HDM-driven allergic airway inflammation experiments. Our data 
indicate that TNFAIP3 depletion in Langerin-expressing cDC1s in-
hibited Th2-mediated immune responses. This was associated with 
an increase in the production of the Th2-suppressive cytokine IL-12 
by cDC1s, leading to increased IFNγ production by CD8+ T cells. 
Increased production of IFNγ subsequently increased the expression 
of the co-inhibitory molecule PD-L1 on all pulmonary DC subsets. 
Strikingly, administration of IFNγ only during HDM sensitization was 
already sufficient to abrogate Th2 development and eosinophilic 
inflammation.
2  | MATERIAL S AND METHODS
2.1 | Mice
Tnfaip3fl/fl mice22 were crossed to Cd207CRE/+ (Langerin-CRE) mice28 
to generate Tnfaip3Lg mice. Tnfaip3Lg mice were crossed to Rosa26-
stop-EYFP reporter (ROSA26flEYFP) mice. Mice were backcrossed 
to the C57BL/6 genetic background for at least six generations. Mice 
were housed and bred under SPF conditions at the Erasmus MC and 
analyzed at 6-12 weeks of age. All experiments were performed with 
approval by the animal ethics committee of the Erasmus MC.
2.2 | HDM-induced allergic airway inflammation
During HDM exposures, mice were anesthetized using isoflurane. 
Mice were sensitized intranasally (i.n.) with 1 μg/40 μL HDM (Greer) 
or 40 μL PBS as a control on day 1 (GIBCO Life Technologies), and 
challenged i.n. on days 7-11 with 10 μg/40 μL HDM.7 Mice were 
killed on day 15. Bronchoalveolar lavage (BAL) was obtained by 
flushing the lungs three times with 1 mL PBS containing 0.5 mM 
EDTA (Sigma-Aldrich). Lungs were either inflated with PBS/OCT (1:1) 
solution and placed in 4% PFA and embedded in paraffin or single-
cell suspensions were prepared.
2.3 | HDM-induced acute immune responses
For the induction of an HDM-mediated acute innate response, mice 
were treated with 100 µg/80 µL of HDM extract intra-tracheally 
(i.t). Twenty-four hours later, single-cell suspensions were obtained 
from lungs by digesting the lungs using DNAse (Sigma) and Liberase 
TM (Roche) for 30 minutes at 37°C.7 After digestion, the lungs were 
homogenized through a 100 μm cell strainer (BD Biosciences). Red 
blood cells were lysed using osmotic lysis buffer (8.3% NH4Cl, 1% 
KHCO3, and 0.04% NA2EDTA in Milli-Q). Cell suspensions were pre-
pared and used for flow cytometry procedures.
2.4 | Antibody treatment of mice during HDM-
induced allergic airway inflammation
To study the effect of IL-12, IFNγ, and PD-L1 on development of 
HDM-induced allergic airway inflammation in Tnfaip3Lg mice, mice 
were treated i.p. with 500 μg anti–IL-12p40 (clone C17/8), 500 μg 
anti-IFNy (clone XMG1.2) antibodies, 250 μg anti–PD-L1 (clone 
MIH5) antibodies or with monoclonal antibody β-galactosidase 
(GL113) as isotype control, 11, 7, 4, and day prior to 1 µg/40 µL HDM 
sensitization on day 0, and at days 0, 3, 7, and 10 during the HDM-
induced allergic airway inflammation model. Fifty ng recombinant 
IFNγ (R&D systems) was administered together with 1 µg/40 µL 
HDM sensitization on day 0. Mice were killed on day 15 after HDM 
sensitization. For the HDM-induced acute immune response, mice 
were treated with monoclonal antibodies or isotype control 10, 7, 4, 
and 1 day prior to 100 µg/80 µL HDM administration on day 0. Mice 
were killed on day 1.
2.5 | Flow cytometry
Single-cell suspensions were prepared from bronchoalveolar lav-
age (BAL) and MLN using standard procedures. MLNs were ho-
mogenized through a 100 μm cell strainer (BD Biosciences). Flow 
cytometry surface and intracellular staining procedures have been 
described previously.23 Monoclonal antibodies used for mouse 
flow cytometric analyses are listed in Table S1. In all experiments, 
dead cells were excluded using Fixable viability dye (eBioscience). 
To measure cytokine production by T cells, cells were stimulated 
at 37°C using 10 ng/mL PMA (Sigma-Aldrich), 250 ng/mL ionomy-
cin (Sigma-Aldrich) and GolgiStop (BD Bioscience), for 4 hours. To 
measure cytokine production by DCs, cells were incubated at 37°C 
in the presence of GolgiPlug (BD Biosciences) for 4 hours. Data were 
acquired using an LSR II flow cytometer (Beckton Dickinson) and 
FACS software (Beckton Dickinson) and analyzed by FlowJo version 
9 (Tree Star Inc software).
2.6 | Lung histology
Five-um-thick paraffin-embedded lung sections were stained with 
periodic acid and Schiffs reagents to visualize mucus-producing cells.
2.7 | ELISA
Total IgE and HDM-specific IgG1 were measured in serum (Opteia, 
BD Biosciences).
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F I G U R E  1   Depletion of TNFAIP3 in Langerin+ cDC1s increased PD-L1 expression and pulmonary DC numbers. (A) Flow cytometry 
histograms of lung DC subsets in C57BL/6 mice showing CD207 expression in cDC1s, cDC2s, moDCs, and pDCs. (B) Quantification of 
the percentage CD207 expression in different DC subsets. (C) Flow cytometric histograms of EYFP expression in lung DC subsets of 
Langerin-cre x Rosa26-stopflEYFP mice. (D) Quantification of the percentage EYFP expression in different DC subsets by flow cytometry 
in BAL, lung, and MLN. (E) EYFP expression in different DC subsets in the lung of Tnfaip3Lg-WTRosa26-stopflEYFP and Tnfaip3Lg-KORosa26-
stopflEYFP mice. (F) Quantification of mean fluorescent intensity of MHCII, CD86, and PD-L1 in lung cDC1s of Tnfaip3Lg-WT mice (n = 6) 
and cDC1s of Tnfaip3Lg-KO (n = 4) by flow cytometry. (G) Quantification of PD-L1 in EYFP- and EYFP+ cDC1s in the lung of Tnfaip3Lg-WT x 
Rosa26-stopflEYFP (n = 6) and Tnfaip3Lg-KO x Rosa26-stopflEYFP mice (n = 4). Results are presented as mean ± SEM of n = 2-7 per group and 
representative of two independent experiments
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2.8 | Statistical analysis
Mann-Whitney U tests were used for comparison between two rel-
evant groups, which either differ only in genotype of the mice, or 
in the protocol/treatment received, and a P-value of <.05 was con-
sidered statistically significant. Analysis was determined using Prism 
(GraphPad Software).
3  | RESULTS
3.1 | Depletion of TNFAIP3 in Langerin+ cDC1s 
increases PD-L1 expressing lung DCs
Langerin (CD207) is expressed in Langerhans cells in the skin 
and in a proportion of pulmonary cDC1s. Consistent with other 
F I G U R E  2   Tnfaip3Lg-KO mice develop reduced Th2-mediated inflammation. (A) Tnfaip3Lg mice were sensitized i.n. with PBS or 1 μg HDM 
on day 0 and challenged i.n. with 10 μg HDM daily between days 7 and 11 to induce allergic airway inflammation. Analysis was performed 
at day 15. (B-C) Numbers of eosinophils, neutrophils, macrophages, B cells, and Tcells determined in BAL by flow cytometric analysis. (D) 
Number of CD4+Tcells in BAL by flow cytometric analysis. (E) Number of IL-5+, IL-13+, and IL-17+ CD4 Tcells in the BAL by flow cytometric 
analysis. (F) Histological analysis of mucus-producing goblet cells in the airways by periodic acid staining. (G) Serum total IgE levels 
determined by ELISA. Results are presented as mean ± SEM of 6 PBS or HDM-sensitized Tnfaip3Lg-WT mice, 2 PBS-sensitized Tnfaip3Lg-KO 
mice, and 5 HDM-sensitized Tnfaip3Lg-KO mice. Results depicted are representative of two or more independent experiments. *P < .05, 
**P < .01
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F I G U R E  3   TNFAIP3 deletion in cDC1s increases PD-L1 and IL-12 expression in all pulmonary DC subsets, together with increased 
IFNγ expression by CD8+ T cells. (A) Flow cytometric histogram showing PD-L1 expression in pulmonary DCs in Tnfaip3Lg mice upon a 
single provocation of PBS or 100 μg HDM. (B) Quantification of MFI of PD-L1 in cDC1s, cDC2s, moDCs, and pDCs of PBS or HDM-treated 
Tnfaip3Lg-WT (n = 6) or Tnfaip3Lg-KO (n = 4) mice by flow cytometry. (C) Flow cytometric histogram of MHCII expression in pulmonary DCs 
upon PBS or HDM treatment. (D) Quantification of MFI of MHCII in cDC1s, cDC2s, moDCs, and pDCs of PBS or HDM-treated Tnfaip3Lg-
WT (n = 6) or Tnfaip3Lg-KO (n = 4) mice by flow cytometry. (E) Flow cytometric gating of pulmonary IL-12-secreting cDC1s. (F) Percentage of 
IL-12 secreting cDC1s in lungs of PBS or HDM-treated Tnfaip3Lg-WT (n = 6) or Tnfaip3Lg-KO (n = 4) mice by flow cytometry. (G) Proportion of 
IFNγ + CD4+ and CD8+ T cells in lungs of Tnfaip3Lg mice 24 h after single PBS or HDM provocation by flow cytometry. (H) Quantification 
of the number of IFNγ+ CD4+ and CD8+ T cells in BAL of Tnfaip3Lg-WT mice (n = 6) and Tnfaip3Lg-KO mice (n = 4) after HDM sensitization and 
challenge. (I) Quantification of the total numbers of IFNγ-producing cells in BAL of HDM-sensitized and HDM-challenged Tnfaip3Lg-WT mice 
(n = 6) and Tnfaip3Lg-KO mice (n = 6) (J) Distribution of IFNγ-expressing cells in the BAL of HDM-sensitized and HDM-challenged Tnfaip3Lg-WT 
mice (n = 6) and Tnfaip3Lg-KO mice (n = 6). Results are presented as mean ± SEM of n = 2-6 mice per group and representative of two or more 
independent experiments. *P < .05, **P < .01
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publications, we also found that Langerin was expressed by 
15% of cDC1s in the lung, whereas in other pulmonary DC sub-
sets, Langerin expression was not detected (Figure 1A,B).28,29 To 
determine whether Langerin-Cre-mediated targeting of cDC1s 
reflects CD207 expression, we crossed Langerin-Cre mice28 to 
Rosa26-stopflEYFP mice (Langerin-cre x Rosa26-stopflEYFP mice). 
F I G U R E  4   Blockage of IFNγ restores eosinophilic airway inflammation in Tnfaip3Lg-KO mice. (A) IL-12p40 and IFNγ were neutralized in 
Tnfaip3Lg mice by i.p. injections with anti–IL-12p40 and anti-IFNγ on days −11, −7, −4, and −1. Tnfaip3Lg mice were sensitized i.n. with PBS 
or 1 μg HDM on day 0 and challenged i.n. with 10 μg HDM daily between days 7 and 11 to induce allergic asthma. Analysis was performed 
at day 15. (B-C) Numbers of eosinophils, neutrophils, macrophages, B cells, and T cells determined in BAL by flow cytometric analysis. (D) 
Enumeration of CD4+ and CD8+ T cells in BAL by flow cytometric analysis. (E-G) Quantification of the number of IL-5+, IFNγ+, and IL-10+ 
CD4+ and CD8+ T cells in BAL by flow cytometry. Results are presented as mean ± SEM of n = 4 PBS-sensitized Tnfaip3Lg-WT mice, n = 6 HD-
sensitized Tnfaip3Lg-WT mice, n = 5 HDM-sensitized Tnfaip3Lg-WT mice that were treated with either anti–IL-12p40 and anti-IFNγ, n = 6 HD-
sensitized Tnfaip3Lg-KO mice, n = 5 HD-sensitized Tnfaip3Lg-KO mice that were treated with anti–IL-12p40, and n = 6 HD-sensitized Tnfaip3Lg-
KO mice that were treated with anti-IFNγ. Results are representative of two independent experiments. *P < .05, **P < .01
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DC subsets were examined according to the gating strategy as 
shown in Figure S1. In the lungs and lung-draining mediastinal 
lymph node (MLN) of naive mice at the age of 6-8 weeks, ap-
proximately 10% of the cDC1s expressed EYFP, whereas in the 
bronchoalveolar lavage (BAL), 35% of cDC1s expressed EYFP 
(Figure 1C,D). Expression of EYFP in other DC subsets in BAL, 
lung, or MLN was below 3%. TNFAIP3 deletion did not affect EYFP 
expression as the proportions of EYFP-expressing pulmonary DCs 
were not different between Tnfaip3Lg-WT and Tnfaip3Lg-KO Rosa26-
stopflEYFP mice (Figure 1E). Since TNFAIP3 deletion affects the 
activation status of DCs,22,23 we determined the expression of 
MHCII, CD86, and PD-L1 on cDC1s. MHCII expression was not 
altered, whereas CD86 expression was significantly decreased, 
and PD-L1 expression was increased on pulmonary cDC1s of 
Tnfaip3Lg-KO mice compared with Tnfaip3Lg-WT mice (Figure 1F). As 
the Cd207 promotor targets only a fraction of pulmonary cDC1s, 
we compared the expression of PD-L1 in EYFP+ and EYFP- cDC1s 
of Tnfaip3Lg x Rosa26-stopflEYFP mice. PD-L1 expression was 
especially increased in EYFP+ cDC1s compared to EYFP- cDC1s 
in Tnfaip3Lg-KO x Rosa26-stopflEYFP mice, suggesting that the in-
creased expression of PD-L1 was caused by a cell intrinsic defect 
caused by loss of Tnfaip3 in cells expressing langerin (Figure S2).
We next investigated whether the Langerin-Cre-mediated 
TNFAIP3 deletion in a fraction of pulmonary cDC1s affected the 
numbers of pulmonary DC subsets. Total DCs and specifically 
cDC2s, moDCs, and plasmacytoid (pDCs) were increased in lungs 
of Tnfaip3Lg-KO mice as compared to controls. The number of cDC1s 
was unaffected in Tnfaip3Lg-KO mice (Figure 1G). As Langerin is 
mainly expressed by Langerhans cells in the skin, we also evalu-
ated the frequency and activation status of Langerhans cells in the 
epidermis, and found no differences in their frequencies between 
Tnfaip3Lg-KO and Tnfaip3Lg-WT mice. In contrast to Tnfaip3-deficient 
cDC1s in the lungs, expression of the co-stimulatory molecule CD86 
was increased in Langerhans cells of Tnfaip3Lg-KO mice as compared 
to Tnfaip3Lg-WT mice (Figure S3).
As DC activation can affect T-cell homeostasis30 and TNFAIP3 
deletion in DCs has been shown to induce autoimmune disease, 
we evaluated Tcells in the lung, MLN, and spleen. Both CD4+ and 
CD8+ T-cell numbers were similar between lung, MLN, and spleen 
of Tnfaip3Lg-KO and Tnfaip3Lg-WT mice (Figure S4), indicating that 
TNFAIP3 deletion selectively in Langerin-expressing DC subsets 
does not induce systemic inflammation or signs of autoimmunity.
In conclusion, these data show that Langerin-expressing cDC1s 
comprise a small proportion of lung cDC1s. TNFAIP3 deletion in 
cDC1s altered their phenotype by decreasing CD86 expression, 
while increasing the expression of the co-inhibitory molecule PD-L1. 
Ablation of TNFAIP3 in Langerin+ cDC1s augmented the numbers of 
pulmonary cDC2s, moDCs, and pDCs, whereas it had no effect on 
T-cell numbers locally nor systemically.
3.2 | Th2-mediated HDM-induced airway 
inflammation is reduced in Tnfaip3Lg-KO mice
To investigate the effects of cDC1-specific TNFAIP3 deficiency on 
Th2-cell differentiation, we exposed Tnfaip3Lg-KO mice to inhaled 
HDM to induce allergic airway inflammation (Figure 2A). As previ-
ously reported,31 HDM sensitization followed by repetitive HDM 
challenge increased eosinophils, B cells, and Tcells in the BAL as com-
pared with PBS sensitization in WT mice (Figure 2B,C). Strikingly, 
HDM-sensitized and HDM-challenged Tnfaip3Lg-KO had reduced 
eosinophil and T-cell numbers in the BAL compared to Tnfaip3Lg-WT 
mice, whereas the numbers of neutrophils, macrophages, and B cells 
were unchanged (Figure 2B,C). Th2 cytokine-secreting CD4+ T-cells 
were increased in HDM-sensitized Tnfaip3Lg-WT mice, whereas 
IL-5+ and IL-13+ Thcells in HDM-sensitized Tnfaip3Lg-KO were not 
F I G U R E  5   IL-12 and IFNγ are essential for PD-L1 expression on DC subsets in Tnfaip3Lg-KO mice. (A) IL-12p40 and IFNγ were neutralized 
in Tnfaip3Lg mice by i.p. injections with anti–IL-12p40 and anti-IFNγ on days −10, −7, −4, and −1. Tnfaip3Lg mice were treated i.t. with PBS or 
100 μg HDM on day 0. Analysis was performed on day 1. (B-C) Quantification of MFI of PD-L1 expression in pulmonary total DCs (B) and 
DC subsets (C) by flow cytometry. Results are presented as mean ± SEM of n = 3-4 mice per group and representative of two independent 
experiments. *P < .05, **P < .01
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elevated as compared with PBS-sensitized controls. In this model, 
IL-17+ was not induced in Th cells (Figure 2E). Serum IgE increased 
upon HDM sensitization and challenge in Tnfaip3Lg-WT mice, but 
not in Tnfaip3Lg-KO mice, compared to PBS-sensitized control mice 
(Figure 2F). Accordingly, upon immunohistochemistry analysis of 
the lungs, HDM-sensitized Tnfaip3Lg-KO mice showed no lung in-
flammation and mucus production, which were readily observed in 
Tnfaip3Lg-WT mice (Figure 2G). As Th2-mediated airway inflammation 
was hampered in HDM-sensitized Tnfaip3Lg-KO mice, we wondered 
whether anti-inflammatory cells would be increased in HDM-
treated Tnfaip3Lg-KO mice. MLNs of both PBS- and HDM-sensitized 
Tnfaip3Lg-KO mice had increased proportions of Foxp3+CD25+ Tregs 
compared to PBS- and HDM-sensitized Tnfaip3Lg-WT mice, respec-
tively (Figure S5). However, this increase in Tregs in Tnfaip3Lg-KO mice 
was not responsible for the reduced Th2-driven immune responses, 
as Tnfaip3Lg-KO mice depleted of Tregs by an anti-CD25–depleting 
antibody (PC61), still failed to develop Th2-driven inflammation 
(Figure S6).
Taken together, these findings indicate that TNFAIP3 dele-
tion in cDC1s hampers the induction of eosinophilia, Th2 cy-
tokine-producing Tcells, and increased serum IgE upon HDM 
exposure. Furthermore, Tnfaip3Lg-KO mice had higher numbers of 
anti-inflammatory Tregs following HDM exposure. Depleting Tregs 
in Tnfaip3Lg-KO mice did not restore Th2-mediated inflammation, 
indicating that Tregs are not essential for the suppression of Th2-
mediated inflammation by TNFAIP3-deficient cDC1s.
3.3 | TNFAIP3 deletion in cDC1s increases their PD-
L1 and IL-12 expression
Tnfaip3Lg-KO mice developed reduced eosinophilic inflammation upon 
HDM sensitization and challenge exposure, and this effect could be 
due to effects during priming or allergen re-challenge. To study ef-
fect of TNFAIP3 loss on DCs during priming, we examined DC subset 
frequencies, migratory capacity, and co-stimulatory marker expres-
sion following a single intra-tracheal high dose of HDM. After HDM 
administration, total DC numbers and moDCs in the lung increased 
in Tnfaip3Lg-WT mice, but not in Tnfaip3Lg-KO mice. cDC1s, cDC2s, 
and pDC numbers were not altered upon HDM exposure in lungs 
of Tnfaip3Lg-WT mice (Figure S7A). Pulmonary cDC1s and cDC2s de-
creased upon HDM exposure in Tnfaip3Lg-KO mice. Since activated 
pulmonary DCs migrate toward the MLN, we also evaluated DC 
numbers in the MLN. Only cDC1s were increased in PBS-treated 
Tnfaip3Lg-KO mice compared to PBS-treated Tnfaip3Lg-WT mice. HDM 
exposure increased the numbers of total DCs, cDC1s, and cDC2s 
similarly in both Tnfaip3Lg-KO and Tnfaip3Lg-WT mice (Figure S7B), in-
dicating that DC migration to the MLN is not affected by Tnfaip3 
deletion in langerin-expressing cDC1s.
As co-inhibitory marker expression and cytokine production by 
DCs are implicated in immune tolerance during a first antigen ex-
posure,32 we examined DC subsets for the expression of the co-in-
hibitory molecules PD-L1, PD-L2, and ICOSL, and the regulatory 
cytokines TGF-β and IL-10 after a single HDM administration. No 
differences were observed in PD-L2, ICOSL, TGF-β, or IL-10 expres-
sion between pulmonary DCs of Tnfaip3Lg-WT and Tnfaip3Lg-KO mice 
(data not shown). PD-L1 was upregulated on all DCs of Tnfaip3Lg-WT 
mice after HDM exposure yet was already elevated in all DCs of 
Tnfaip3Lg-KO mice in steady state (PBS) and further increased by 
HDM in cDC1s of Tnfaip3Lg-KO mice. However, after HDM provoca-
tion, PD-L1 levels are similar between DC subsets of Tnfaip3Lg-WT 
and Tnfaip3Lg-KO mice (Figure 3A,B and Figure S8A). Surprisingly, 
cDC2s and moDCs in Tnfaip3Lg-KO mice fail to upregulate MHCII in 
response to HDM as compared to Tnfaip3Lg-WT mice (Figure 3C,D 
and Figure S8B).
Everts et al16 previously demonstrated that IL-12 secretion by 
cDC1s is essential for inhibiting Th2 immune responses against 
helminths. Alongside the Th2 suppressive properties of IL-12, it is 
also essential for IFNγ production by CD8+ T cells.33 Similarly, we 
found enhanced production of IL-12, most predominantly in lung 
cDC1s but not in other DC subsets of PBS-treated Tnfaip3Lg-KO mice 
(Figure 3E,F, Figure S8C and data not shown).
These data imply that TNFAIP3 deletion in cDC1s specifically 
elevated the expression of IL-12 only in Tnfaip3-deficient cDC1s. 
Furthermore, the co-inhibitory molecule PD-L1 was increased on 
Tnfaip3-deficient cDC1s, and unexpectedly also in all other lung DC 
subsets that did not intrinsically lacked TNFAIP3.
3.4 | IFNγ expression is increased by T cells of 
Tnfaip3Lg-KO mice
As IL-12 expression by cDC1s and PD-L1 in all DC subsets was in-
creased in PBS-treated and HDM-treated Tnfaip3Lg-KO mice, we 
wondered whether this was accompanied by induction of IFNγ 
expression in T cells upon HDM exposure, as PD-L1 is a type I in-
terferon-inducible protein.34 We first investigated whether IFNγ ex-
pression was already induced upon a single HDM exposure. Both the 
proportion of IFNγ-producing CD4+ and CD8+ T cells were already 
augmented in lungs of PBS-treated Tnfaip3Lg-KO mice as compared to 
control mice (Figure 3G). HDM exposure specifically induced IFNγ-
producing CD8+ T cells in both Tnfaip3Lg-WT and Tnfaip3Lg-KO mice 
(Figure 3G). In contrast, in the acute HDM-driven allergic inflamma-
tion model IFNγ expression in CD4+ T cells was not induced upon 
HDM sensitization, whereas the number of IFNγ+ CD8+ T cells was 
specifically increased in BAL of HDM-sensitized Tnfaip3Lg-KO mice, 
whereas this was not observed in Tnfaip3Lg-WT mice (Figure 3G,H).
Next, we evaluated whether the increase in IFNγ expression 
was specific for CD8+ T cells, and not by other cells, by gating first 
all IFNγ expressing cells (Figure S9). The total amount of IFNγ ex-
pressing cells in the BAL was not different between HDM-sensitized 
Tnfaip3Lg-WT and Tnfaip3Lg-KO mice (Figure 3I). Also, of all IFNγ ex-
pressing cells, the majority is expressed by CD4+ T cells, but only the 
expression of IFNγ in CD8+ T cells was increased in HDM-sensitized 
and HDM-challenged Tnfaip3Lg-KO mice (Figure 3J). Also, IFNγ ex-
pression by other cells, that are not T cells, which could include 
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ILC1s or macrophages was decreased in BAL of HDM-sensitized and 
HDM-challenged Tnfaip3Lg-KO mice (Figure 3J).
In conclusion, these data indicate that mice harboring TNFAIP3-
deficient Langerin+ cDC1s especially displayed increased numbers of 
IFNγ-producing CD8+ T cells upon either a single HDM exposure or 
repetitive exposure with HDM.
3.5 | Blockade of IFNγ restores eosinophilic airway 
inflammation in Tnfaip3Lg-KO mice
Both the numbers of IL-12–expressing cDC1s and IFNγ-producing 
CD8+ T cells were enhanced in Tnfaip3Lg-KO mice. Previous work demon-
strated that both of these populations can efficiently suppress Th2 im-
mune responses.16,35-37 Accordingly, we found that when we exposed 
mice to recombinant IFNγ during HDM sensitization, eosinophilia was 
significantly reduced (data not shown). To determine whether IL-12 
or IFNγ were crucial in the suppression of Th2-mediated eosinophilic 
airway inflammation in Tnfaip3Lg-KO mice, we used antibodies to block 
IL-12p40 or IFNγ starting 10 days before antigen sensitization in the 
HDM-induced allergic airway inflammation model (Figure 4A). Blocking 
IFNγ completely restored eosinophilic, neutrophil, macrophage, B-cell, 
and T-cell infiltration in BAL of HDM-treated Tnfaip3Lg-KO mice to lev-
els found in HDM-treated Tnfaip3Lg-WT mice (Figure 4B,C). Blockade of 
IL-12 partially (eosinophils, neutrophils) or completely (macrophages, 
B cells, and T cells) restored infiltration in BAL of HDM-exposed 
Tnfaip3Lg-KO mice, as compared to HDM-treated Tnfaip3Lg-WT mice 
(Figure 4B,C). Blocking either IL-12 or IFNγ did not alter Th or CD8+ 
T-cell numbers, but increased IL-5 expression specifically in CD8+ T 
cells as compared to isotype-treated Tnfaip3Lg-KO mice (Figure 4D,E). 
Furthermore, anti-IFNγ antibody treatment strongly reduced the num-
ber of IFNγ+ Th cells and CD8+ T cells and IL-10+ Th cells and CD8+ T 
cells in Tnfaip3Lg-KO mice as compared to isotype-treated Tnfaip3Lg-KO 
mice to similar numbers as observed in Tnfaip3Lg-WT mice (Figure 4F,G).
These data imply that blocking IFNγ restores development of 
Th2-mediated allergic airway inflammation in Tnfaip3Lg-KO mice and 
IL-12 is partially or indirectly involved.
3.6 | IL-12 and IFNγ are essential for the enhanced 
PD-L1 expression on DC subsets in Tnfaip3Lg-KO mice
IL-12 is essential for the induction of IFNγ secretion by CD8+ T 
cells,33 and IFNγ can subsequently induce PD-L1 expression.38 
To determine whether IL-12, IFNγ, or both are responsible for 
the increased PD-L1 expression as observed in pulmonary DCs 
of Tnfaip3Lg-KO mice, we treated mice with anti–IL-12p40 or anti-
IFNγ antibodies for 10 days prior to a single HDM exposure 
(Figure 5A). Strikingly, blocking IL-12 completely prevented PD-L1 
upregulation after HDM exposure in all pulmonary DC subsets of 
Tnfaip3Lg-KO mice. Anti-IFNγ antibodies also inhibited the upregu-
lation of PD-L1 in DCs of Tnfaip3Lg-KO mice, although less vigor-
ously than anti–IL-12 treatment (Figure 5B).
We therefore conclude that IL-12p40 or IFNγ blockade can sep-
arately reduce the increased expression of PD-L1 on DC subsets in 
Tnfaip3Lg-KO mice, and could therefore be essential for the increase in 
PD-L1 expression on all pulmonary DC subsets after HDM exposure 
in Tnfaip3Lg-KO mice.
4  | DISCUSSION
DCs are critically involved in the pathogenesis of Th2-mediated dis-
orders; however, the exact function of cDC1s in allergic asthma is 
still debated, as it has been shown that cDC1s can either suppress 
or induce Th2-mediated inflammation.11,13,14,16 Our results indicate 
that TNFAIP3 deletion in Langerin+ cDC1s elevated IL-12 expression 
specifically in cDC1s. Increased IL-12 expression by Tnfaip3-deficient 
cDC1s could provoke an augmented IFNγ production by CD8+ T cells. 
In turn, IFNγ was responsible for the enhanced PD-L1 expression on 
all pulmonary DC subsets. IFNγ during sensitization controlled the 
development of Th2-mediated allergic inflammation upon HDM.
Our observation that mice harboring TNFAIP3-deficient 
Langerin+ cDC1s do not develop Th2-mediated inflammation upon 
exposure to HDM agrees with other reports that cDC1s suppress 
Th2-mediated pulmonary inflammation upon helminth infec-
tion,16 ovalbumin sensitization,10,39 and chronic HDM exposure.11 
Additionally, Helicobacter pylori infection suppresses allergic airway 
inflammation through activation of cDC1s.40 In contrast, others have 
reported that cDC1s are essential for the induction of Th2-mediated 
differentiation in response to HDM13,15 and that depleting cDC1s 
attenuates Th2-mediated eosinophilic inflammation.13,14,41 These 
conflicting findings may be due to the type of allergen used, tim-
ing of administration, or the use of different mouse models, such 
as Basic Leucine Zipper ATF-Like Transcription Factor 3 (BATF3)KO 
mice,10,11,16 BHX2 mice13 that harbor a spontaneous point mutation 
(R294C) of IRF8, Langerin-DTR mice,7 CD103KO mice,39,41 or XCR1KO 
mice.14 Furthermore, the lung is unique, as pulmonary cDC1s con-
tain a mixture of Langerin+ and Langerin- cDC1s.28,42 Differences in 
ontogeny and function between Langerin+ and Langerin- cDC1s are 
currently unknown. Specific deletion of lung Langerin+ cDC1s using 
Langerin-DTR mice did not affect eosinophilic inflammation,7 which 
could indicate that activation of these Langerin+ cDC1s provides an 
additional trigger enhancing their Th2-suppressive character.
Various reports have established cDC1s as major IL-12 produc-
ers that drive protective Th1 immunity against several pathogens.43 
IL-12 production by cDC1s is also known to inhibit Th2 immune re-
sponses during chronic Schistosoma mansoni infection.16 Additionally, 
IL-12–producing DCs, established through retroviral overexpression, 
are also unable to prime mice for pulmonary Th2-mediated eosino-
philic inflammation.44 There are case reports describing that block-
ing IL-12 with ustekinumab (monoclonal antibody to the p40 subunit 
of IL-12 and IL-23) in psoriasis patients exacerbated their atopic der-
matitis,45 indicating a possible role for IL-12 in regulating ongoing 
Th2 responses, next to controlling the induction of Th2 immunity. 
Somewhat unexpected considering the increased IL-12 expression, 
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we did not observe enhanced Th1-cell differentiation, but rather an 
increase in IFNγ-production by CD8+ T cells, which is also dependent 
on IL-12.33 The specific increase in IFNγ-producing CD8+ T cells and 
not IFNγ-producing Th cells may be related to the unique cross-pre-
senting capacities of cDC1s, which allow cDC1s to load exogenous 
peptides on MHCI molecules, making them superior inducers of 
CD8+ T-cell activation.8,9 Increased numbers of IFNγ-expressing 
T cells were already found in the lungs of naïve Tnfaip3Lg-KO mice. 
These are likely induced by TNFAIP3-deficient cDC1s in the lungs; 
however, we cannot exclude that the IFNγ-expressing T cells in the 
lung were partly induced by TNFAIP3-deficient Langerhans cells in 
the skin, because skin DCs have been reported to mediate inflamma-
tion in the airways through the skin-lung axis.5
Furthermore, the presence of CD8+ T cells, and specifically al-
lergen-specific CD8+ T cells, hampers the development of allergic 
diseases.37,46,47 The inhibitory effect of CD8+ T cells is likely caused 
by increased IFNγ production and was most pronounced during the 
sensitization phase, as blocking IFNγ during the challenge phase had 
no effect on Th2-mediated inflammation.46 This was confirmed by 
our findings that administration of IFNγ during sensitization reduced 
Th2-mediated HDM-triggered inflammation. Strikingly, CD8+ T cells 
also contribute to Th2-mediated inflammation by secretion of type-2 
cytokines.46 We also found that blocking IL-12 or IFNγ promoted IL-5 
expression and reduced IFNγ expression in CD8+ T cells, which is in 
line with previous reports that IL-12 is implicated in the induction of 
IFNγ.48 In conclusion, this indicates that the environment is a crucial 
determinant of cytokine expression by CD8+ T cells.
In our experiments, the IL-12p40 subunit was blocked, which 
is used by both IL-12 and IL-23. However, previous reports showed 
that Tnfaip3-deficient cDC1s do not express IL-23,23 and identified 
cDC1s as key producers of IL-12,16,43,49 making it most likely that the 
observed effects were mediated by blocking IL-12.
In conclusion, our data establish that mice harboring Tnfaip3-
deficient Langerin+ cDC1s develop a strongly reduced Th2-mediated 
inflammation in response to HDM which is accompanied by the in-
duction of IFNγ-producing CD8+ T cells and increased PD-L1 expres-
sion on pulmonary DCs. This indicates that the activation status of 
pulmonary cDC1s critically controls development of Th2-mediated 
allergic disorders.
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